Inhibitors of anthrax lethal factor

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 16, 2007, Pages 4575-4578

  Gaddis, Brandon D ^a   Avramova, Larisa V ^a   Chmielewski, Jean ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Anthrax; Inhibitor; Lethal factor

Indexed keywords

ANTHRAX TOXIN; DOPAMINE DERIVATIVE; OLEOYL DOPAMINE; UNCLASSIFIED DRUG;

ANTHRAX; ARTICLE; CELL DEATH; DRUG DETERMINATION; DRUG INHIBITION; DRUG POTENCY; DRUG SYNTHESIS; IC 50; LETHAL GENE; NONHUMAN;

ANTIGENS, BACTERIAL; BACTERIAL TOXINS; DOPAMINE; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34447307647     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.05.089     Document Type: Article

References (32)

1. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., and Vande Woude G.F. Science 280 (1998) 734
2. Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M., and Montecucco C. Biochem. Biophys. Res. Comm. 248 (1998) 706
3. Montecucco C., Tonello F., and Zanotti G. Trends Biochem. Sci. 29 (2004) 282
4. Vitale G., Bernardi L., Napolitani G., Mock M., and Montecucco C. Biochem. J. 352 (2000) 739
5. Biondi R.M., and Nebreda A.R. Biochem. J. 372 (2003) 1
6. Tanoue T., and Nishida E. Cell. Signalling 15 (2003) 455
7. Bardwell A.J., Abdollahi M., and Bardwell L. Biochem. J. 378 (2004) 569
8. Pezard C., Berche P., and Mock M. Infect. Immun. 59 (1991) 3472
9. Tonello F., Seveso M., Marin O., Mock M., and Montecucco C. Nature 418 (2002) 386
10. Xiong Y., Wiltsie J., Woods A., Guo J., Pivnichny J.V., Tang W., Bansal A., Cummings R.T., Cunningham B.R., Friedlander A.M., Douglas C.M., Salowe S.P., Zaller D.M., Scolnick E.M., Schmatz D.M., Bartizal K., Hermes J.D., MacCoss M., and Chapman K.T. Bioorg. Med. Chem. Lett. 16 (2006) 964
11. Dell'Aica I., Donà M., Tonello F., Piris A., Mock M., Montecucco C., and Gargisa S. EMBO Reports 5 (2004) 418
12. Numa M.M.D., Lee L.V., Hsu C.-C., Bower K.E., and Wong C.-H. ChemBioChem 6 (2005) 1002
13. Panchal R.G., Hermone A.R., Nguyen T.L., Wong T.Y., Schwarzenbacher R., Schmidt J., Lane D., McGrath C., Turk B.E., Burnett J., Aman M.J., Little S., Sausville E.A., Zaharevitz D.W., Cantley L.C., Liddington R.C., Gussio R., and Bavari S. Nat. Struct. Biol. 11 (2004) 67
14. Johnson S., Jung D., Forino M., Chen Y., Satterthwait A., Rozanov D.V., Strongin A.Y., and Pellecchia M. J. Med. Chem. 49 (2006) 27
15. Min D.-H., Tang W.-J., and Mrksich M. Nat. Biotechnol. 22 (2004) 717
16. Schepetkin I.A., Khlebnikov A.I., Kirpotina L.N., and Quinn M.T. J. Med. Chem. 49 (2006) 5232
17. Lee L.V., Bower K.E., Liang F.-S., Wu D., Sucheck S.J., Vogt P.K., and Wong C.-H. J. Am. Chem. Soc. 126 (2004) 4774
18. Fridman M., Belakhov V., Lee L.V., Liang F.-S., Wong C.-H., and Baasov T. Angew. Chem., Int. Ed. 44 (2005) 447
19. Jiao G.-S., Cregar L., Goldman M.E., Millis S.Z., and Tang C. Bioorg. Med. Chem. Lett. 16 (2006) 1527
20. Jiao G.-S., Simo O., Nagata M., O'Malley S., Hemscheidt T., Cregar L., Millis S.Z., Goldman M.E., and Tang C. Bioorg. Med. Chem. Lett. 16 (2006) 5183
21. Goldman M.E., Cregar L., Nguyen D., Simo O., O'Malley S., and Humphreys T. BMC Pharmacol. 6 (2006) 8
22. Lethal toxin challenge conditions: J774A.1 cells were allowed to grow to confluency in 96-well plates before 3 nM PA, LOPAC 1280 (Sigma) library members or compounds 1-6 (0.6% DMSO), and 0.61 nM LF (List Biological Laboratories) were added to the cells. Cells were allowed to incubate with the PA/LF/compound mixture for 4 h at 37 °C before MTT was added. Cells were allowed to incubate for an additional 1.5 h at 37 °C before cell viability was determined.
23. Cummings R.T., Salowe S.P., Cunningham B.R., Wiltsie J., Park Y.W., Sonatore L.M., Wisniewski D., Douglas C.M., Hermes J.D., and Scolnick E.M. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6603
24. 50): compounds 1-6 (0.6% DMSO) were incubated with 50 nM LF (List Biological Laboratories) in assay buffer (65 μL) for 1 h before addition to 4 μM MAPKKide (List Biological Laboratories) in assay buffer (10 μL). Fluorescent measurements were performed over 10 min (excitation and emission of 485 and 590, respectively). Assay buffer consisted of 20 mM Hepes, pH 7.4.
25. Chu C.J., Huang S.M., De Petrocellis L., Bisogno T., Ewing S.A., Miller J.D., Zipkin R.E., Daddario N., Appendino G., Di Marzo V., and Walker J.M. J. Biol. Chem. 278 (2003) 13633
26. i): compounds 1, 4 and 6 (1.6% DMSO) were incubated with 12.5 nM LF (List Biological Laboratories) in assay buffer (65 μL) for 1 h before addition to 6-12 μM MAPKKide (List Biological Laboratories) in assay buffer (10 μL). Fluorescent measurements were performed over 10 min (excitation and emission of 485 and 590, respectively). Assay buffer consisted of 20 mM Hepes, pH 7.4.
27. Pannifer A.D., Wong T.Y., Schwarzenbacher R., Renatus M., Petosa C., Bienkowska J., Lacy D.B., Collier R.J., Park S., Leppla S.H., Hanna P., and Liddington R.C. Nature 414 (2001) 229
28. Bodini M.E., Copia G., Robinson R., and Sawyer D.T. Inorg. Chem. 22 (1983) 126
29. +).
30. +).
31. Cytotoxicity study: J774A.1 cells were allowed to grow to confluency in 96-well plates before 0-100 μM compound in media (0.6% DMSO) was added to the cells. Cells were allowed to incubate with the compound mixture for 4 h at 37 °C before MTT was added. Cells were allowed to incubate for an additional 1.5 h at 37 °C before cell viability was determined.
32. +).